Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: A systematic review

Family Practice

Volumn 30, Issue 3, 2013, Pages 247-255

  Nderitu, Paul ^a   Doos, Lucy ^a   Jones, Peter W ^a   Davies, Simon J ^a   Kadam, Umesh T ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

Disease progression; General practice; Glomerular filtration rate; Kidney disease; Nonsteroidal anti inflammatory agents; Systematic review

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; DISEASE COURSE; GENERAL PRACTICE; HUMAN; META ANALYSIS; RISK ASSESSMENT; SYSTEMATIC REVIEW;

DISEASE PROGRESSION; GENERAL PRACTICE; GLOMERULAR FILTRATION RATE; KIDNEY DISEASE; NON-STEROIDAL ANTI-INFLAMMATORY AGENTS; SYSTEMATIC REVIEW.;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK;

EID: 84878655206     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cms086     Document Type: Article

References (54)

1. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39 (suppl 1): S1-S266.
2. Stevens PE, O'Donoghue DJ, de Lusignan S et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 2007; 72: 92-9.
3. The National Collaborating Centre for Chronic Conditions. Chronic Kidney Disease: National Clinical Guideline for Early Identification and Management in Adults in Primary and Secondary Care. London: Royal College of Physicians, 2008.
4. Evans PD, Taal MW. Epidemiology and causes of chronic kidney disease. Medicine 2011; 39(7): 402-6.
5. Meguid El Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005; 365: 331-40.
6. Levey AS, Coresh J. Chronic kidney disease. Lancet 2011; 379(9811): 165-80.
7. Murray MD, Black PK, Kuzmik DD et al. Acute and chronic effects of nonsteroidal antiinflammatory drugs on glomerular filtration rate in elderly patients. Am J Med Sci 1995; 310: 188-97.
8. Ibáñez L, Morlans M, Vidal X, Martínez MJ, Laporte JR. Casecontrol study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease. Kidney Int 2005; 67: 2393-8.
9. Morlans M, Laporte JR, Vidal X, Cabeza D, Stolley PD. End-stage renal disease and non-narcotic analgesics: a case-control study. Br J Clin Pharmacol 1990; 30: 717-23.
10. Fored CM, Ejerblad E, Lindblad P et al. Acetaminophen, aspirin, and chronic renal failure. N Engl J Med 2001; 345: 1801-8.
11. Brooks P. Use and benefits of nonsteroidal anti-inflammatory drugs. Am J Med 1998; 104(3A): 9S-13S.
12. Maxwell CJ, Dalby DM, Slater M et al. The prevalence and management of current daily pain among older home care clients. Pain 2008; 138: 208-16.
13. Bhopal S, Chan J, Ellis O et al. Non-steroidal anti-inflammatory drugs prescribing in chronic kidney disease: an observational study. Prim Health Care Res Dev 2010; 11(03): 280-84.
14. James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet 2010; 375: 1296-309.
15. Rosenberg M, Kalda R, Kasiulevicius V, Lember M; European Forum for Primary Care. Management of chronic kidney disease in primary health care: position paper of the European Forum for Primary Care. Qual Prim Care 2008; 16: 279-94.
16. Burden R, Tomson C; Guideline Development Committee, Joint Specialty Committee on Renal Disease of the Royal College of Physicians of London and the Renal Association. Identification, management and referral of adults with chronic kidney disease: concise guidelines. Clin Med 2005; 5: 635-42.
17. McLaughlin JK, Lipworth L, Chow WH, Blot WJ. Analgesic use and chronic renal failure: a critical review of the epidemiologic literature. Kidney Int 1998; 54: 679-86.
18. Delzell E, Shapiro S. A review of epidemiologic studies of nonnarcotic analgesics and chronic renal disease. Medicine (Baltimore) 1998; 77: 102-21.
19. Critical Appraisal Skills Program. Appraisal tools. CASP International Network, 2006. http://www.caspinternational.org/?o=1012 (accessed 15 November 2011).
20. Gooch K, Culleton BF, Manns BJet al. NSAID use and progression of chronic kidney disease. Am J Med 2007; 120: 280.e1-7.
21. Yarger S, Nwokeji E, Trice S et al. Cumulative exposure to nonsteroidal anti-inflammatory drugs (nsaids) and the progression of chronic kidney disease (ckd). Value in Health 2011; 14(3): A74-A75.
22. Hemmelgarn BR, Culleton BF, Ghali WA. Derivation and validation of a clinical index for prediction of rapid progression of kidney dysfunction. QJM 2007; 100: 87-92.
23. Evans M, Fored CM, Bellocco R et al. Acetaminophen, aspirin and progression of advanced chronic kidney disease. Nephrol Dial Transplant 2009; 24: 1908-18.
24. Agodoa LY, Francis ME, Eggers PW. Association of analgesic use with prevalence of albuminuria and reduced GFR in US adults. Am J Kidney Dis 2008; 51: 573-83.
25. Hippisley-Cox J, Coupland C. Predicting the risk of chronic Kidney Disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores. BMC Fam Pract 2010; 11: 49.
26. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
27. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function- measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473-83.
28. Signorello LB, McLaughlin JK, Lipworth L, Friis S, Sørensen HT, Blot WJ. Confounding by indication in epidemiologic studies of commonly used analgesics. Am J Ther 2002; 9: 199-205.
29. Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2009 [updated March 2011]. http://www. cochrane-handbook.org (accessed 01 January 2012).
30. Kamper AL. The importance of a correct evaluation of progression in studies on chronic kidney disease. Nephrol Dial Transplant 2007; 22: 3-5.
31. Curhan GC, Knight EL, Rosner B, Hankinson SE, Stampfer MJ. Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med 2004; 164: 1519-24.
32. Kurth T, Glynn RJ, Walker AM et al. Analgesic use and change in kidney function in apparently healthy men. Am J Kidney Dis 2003; 42(2): 234-44.
33. Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 2006; 69: 375-82.
34. Sun J, Gooch K, Novak K, Svenson LW, Frank C. Prevalence of NSAID use among Alberta seniors in 2002-2003. Ann Epidemiol 2004; 14(8): 603.
35. Chrischilles EA, Foley DJ, Wallace RB et al. Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. J Gerontol 1992; 47(5): M137-44.
36. Murray TG, Stolley PD, Anthony JC, Schinnar R, Hepler-Smith E, Jeffreys JL. Epidemiologic study of regular analgesic use and end-stage renal disease. Arch Intern Med 1983; 143: 1687-93.
37. Sandler DP, Smith JC, Weinberg CR et al. Analgesic use and chronic renal disease. N Engl J Med 1989; 320: 1238-43.
38. Rexrode KM, Buring JE, Glynn RJ, Stampfer MJ, Youngman LD, Gaziano JM. Analgesic use and renal function in men. JAMA 2001; 286: 315-21.
39. van der Woude FJ, Heinemann LA, Graf H et al. Analgesics use and ESRD in younger age: a case-control study. BMC Nephrol 2007; 8: 15.
40. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 1994; 331: 1675-9.
41. Kuo HW, Tsai SS, Tiao MM, Liu YC, Lee IM, Yang CY. Analgesic use and the risk for progression of chronic kidney disease. Pharmacoepidemiol Drug Saf 2010; 19: 745-51.
42. Murray MD, Brater DC, Tierney WM, Hui SL, McDonald CJ. Ibuprofen-associated renal impairment in a large general internal medicine practice. Am J Med Sci 1990; 299: 222-9.
43. Stürmer T, Erb A, Keller F, Günther KP, Brenner H. Determinants of impaired renal function with use of nonsteroidal anti-inflammatory drugs: the importance of half-life and other medications. Am J Med 2001; 111: 521-7.
44. Sandler DP, Burr FR, Weinberg CR. Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Ann Intern Med 1991; 115: 165-72.
45. Segasothy M, Samad SA, Zulfigar A, Bennett WM. Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic. Am J Kidney Dis 1994; 24: 17-24.
46. Sorensen AW. Is the relation between analgesics and renal disease coincidental and not causal?Nephron 1966; 3: 366-76.
47. Lawson DH. Analgesic consumption and impaired renal function. J Chronic Dis 1973; 26: 39-45.
48. Dubach UC, Rosner B, Pfister E. Epidemiologic study of abuse of analgesics containing phenacetin. Renal morbidity and mortality (1968-1979). N Engl J Med 1983; 308: 357-62.
49. Corwin HL, Bonventre JV. Renal insufficiency associated with nonsteroidal anti-inflammatory agents. Am J Kidney Dis 1984; 4: 147-52.
50. McCredie M, Stewart JH. Does paracetamol cause urothelial cancer or renal papillary necrosis? Nephron 1988; 49: 296-300.
51. Pommer W, Bronder E, Greiser Eet al. Regular analgesic intake and the risk of end-stage renal failure. Am J Nephrol 1989; 9: 403-12.
52. Steenland NK, Thun MJ, Ferguson CW, Port FK. Occupational and other exposures associated with male end-stage renal disease: a case/control study. Am J Public Health 1990; 80: 153-7.
53. Elseviers MM, De Broe ME. A long-term prospective controlled study of analgesic abuse in Belgium. Kidney Int 1995; 48: 1912-9.
54. Plantinga L, Grubbs V, Sarkar U et al.; CDC CKD Surveillance Team. Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States. Ann Fam Med 2011; 9: 423-30.